Minapharm Pharmaceuticals

ACTIVE

Egyptwww.minapharm.comPublic1,001–5,000 employeesEstablished: 1958-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1958

Overview

Trial Phase Distribution

Phase

Trials

Phase 4

100.0%

Trial Status Distribution

Recruiting

42.9%

Unknown

57.1%

Clinical Trials

Trials sponsored by this organization (7)

Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis

Phase 4

Recruiting

interventional

Nov 2022100 participants

Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease Patients

Phase 4

Recruiting

interventional

Feb 2022297 participants

Study to Assess the Safety & Efficacy of Oral Ciprodiazole Versus Currently Used Ciprofloxacin & Metronidazole

Phase 4

Recruiting

interventional

Aug 2021312 participants

Gonapure® in Multifollicular Stimulation in Egyptian Women Undergoing IVF/ICSI

Phase 4

Unknown

interventional

Feb 2017200 participants

Topical r-Hirudin ( Thrombexx ) Efficacy in Treatment of Haematomas

Phase 4

Unknown

interventional

Oct 2013200 participants

Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population

Phase 4

Unknown

interventional

Jun 2013300 participants

Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C

Phase 4

Unknown

interventional

Aug 20125,000 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations